Table 1.
OS | DFS | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Univariate | Multivariate | Univariate | Multivariate | |||||||||
Factor | HR | 95% CI | p Value | HR | 95% CI | p Value | HR | 95% CI | p Value | HR | 95% CI | p Value |
Sex (male) | 1.265 | 0.254–6.300 | 0.774 | 1.693 | 0.496–5.786 | 0.401 | ||||||
Age (years) | 1.008 | 0.941–1.080 | 0.815 | 1.028 | 0.981–1.076 | 0.249 | ||||||
Liver cirrhosis
(yes vs. no) |
3.747 | 0.450–31.170 | 0.222 | 0.747 | 0.280–1.994 | 0.560 | ||||||
Platelet (109/L) | 1.002 | 0.993–1.011 | 0.627 | 1.007 | 1.001–1.012 | 0.015 | 1.015 | 1.005 – 1.024 | 0.002 | |||
Albumin (g/dL) | 0.685 | 0.323–1.451 | 0.323 | 0.713 | 0.464–1.096 | 0.123 | ||||||
Total bilirubin (mg/dL) | 1.502 | 1.083–2.083 | 0.015 | 1.380 | 0.993–1.917 | 0.055 | ||||||
Creatinine (mg/dL) | 0.005 | 0.000–0.838 | 0.043 | 0.187 | 0.013–2.608 | 0.212 | ||||||
Serum AST
(U/L) |
1.002 | 0.996–1.007 | 0.588 | 1.001 | 0.996–1.006 | 0.790 | ||||||
Serum ALT
(U/L) |
1.007 | 1.000–1.013 | 0.035 | 1.005 | 1.000–1.010 | 0.057 | ||||||
Serum AFP (ng/mL) | 1.000 | 1.000–1.000 | <0.001 | 1.000 | 1.000 – 1.000 | 0.003 | 1.000 | 1.000–1.000 | 0.003 | |||
PIVKA II (mAU/mL) | 1.000 | 1.000–1.000 | 0.003 | 1.000 | 1.000–1.000 | 0.002 | ||||||
MVI
(yes vs no) |
0.002 | 0.000–7.853 | 0.144 | 13.464 | 4.210–43.055 | <0.001 | 18.674 | 4.103 – 84.996 | <0.001 | |||
mUICC
(III-IV vs. I-II) |
17.153 | 2.092–140.608 | 0.008 | 7.691 | 2.889–20.473 | <0.001 | ||||||
Tumor grade
(3–4 vs. 1–2) |
0.045 | 0.000–32,060.773 | 0.653 | 22.504 | 0.004–144,372.189 | 0.486 | ||||||
SNRPB | 5.672 | 1.051–30.609 | 0.044 | 4.550 | 1.496–13.836 | 0.008 | ||||||
CETN2 | 4.742 | 1.280–17.572 | 0.020 | 3.259 | 1.361–7.801 | 0.008 | ||||||
HMGA1 | 4.065 | 1.244–13.288 | 0.020 | 3.166 | 1.562–6.415 | 0.001 | 2.905 | 1.148 – 7.353 | 0.024 | |||
MPZL1 | 1.435 | 0.506–4.073 | 0.497 | 1.300 | 0.654–2.584 | 0.453 | ||||||
RACGAP1 | 6.631 | 2.375–18.519 | <0.001 | 34.162 | 3.486 – 334.737 | 0.002 | 5.212 | 2.386–11.383 | <0.001 |